Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

676
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
676
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Association Between Atopic Dermatitis and Select Disease Events in Adults in the United States: A Retrospective Cohort Study in the Optum Electronic Health Records Database.

Dermatology and therapy·2025
Same author

Informatics and Artificial Intelligence-Guided Assessment of the Regulatory and Translational Research Landscape of First-in-Class Oncology Drugs in the United States, 2018-2022.

JCO clinical cancer informatics·2024
Same author

Racial differences in patient-reported outcomes among men treated with radical prostatectomy for prostate cancer.

The Prostate·2023
Same author

Rates of cardiovascular events among patients with moderate-to-severe atopic dermatitis in an integrated health care system: A retrospective cohort study.

PloS one·2022
Same author

Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritis.

British journal of clinical pharmacology·2022
Same author

Health-Care Utilization and Expenditures Associated with Long-Term Treatment After Combat and Non-Combat-Related Orthopaedic Trauma.

The Journal of bone and joint surgery. American volume·2022
Same journal

Multimodule Human-Artificial Intelligence Collaboration Pipeline for Large Language Model-Assisted Thematic Analysis Across Digital Health Interview Studies: Comparative Evaluation Study.

JMIR medical informatics·2026
Same journal

Graph Network Feature Space Fusion for Predicting Irregularly Sampled Medical Time-Series Data: Deep Learning Model Development and Validation Study.

JMIR medical informatics·2026
Same journal

Intrasystem Repeatability of S-Detect for Breast Ultrasound Classification With Identical Static Images: Single-Center Retrospective Repeatability Study.

JMIR medical informatics·2026
Same journal

Clinician Perspectives on Ambient AI Scribes in the Intensive Care Unit: Qualitative Interview Study.

JMIR medical informatics·2026
Same journal

IdeaDistiller-AI Support for Idea Synthesis in Concept Mapping: Algorithm Development and Validation Study.

JMIR medical informatics·2026
Same journal

Pregnancy-Related Clinical Codes in Unlikely Populations in Primary Care.

JMIR medical informatics·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

510

Practical Aspects of Using Large Language Models to Screen Abstracts for Cardiovascular Drug Development:

Jay G Ronquillo1, Jamie Ye1, Donal Gorman2

  • 1Worldwide Medical and Safety, Pfizer Research and Development, Pfizer Inc, New York, NY, United States.

JMIR Medical Informatics
|October 4, 2024
PubMed
Summary
This summary is machine-generated.

Three large language models were evaluated for accelerating cardiovascular drug development literature screening. They offer performance, cost, and prompt engineering trade-offs for efficient data synthesis.

Keywords:
AIGPTLLMartificial intelligencebiomarkerbiomedicalbiomedical informaticscardiocardiologycardiovascularcross-sectional studydrugdrug developmentlarge language modelscreening optimization

More Related Videos

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K
Large Scale Zebrafish-Based In vivo Small Molecule Screen
07:03

Large Scale Zebrafish-Based In vivo Small Molecule Screen

Published on: December 30, 2010

13.4K

Related Experiment Videos

Last Updated: Jun 11, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

510
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K
Large Scale Zebrafish-Based In vivo Small Molecule Screen
07:03

Large Scale Zebrafish-Based In vivo Small Molecule Screen

Published on: December 30, 2010

13.4K

Area of Science:

  • Pharmacology
  • Artificial Intelligence
  • Biomedical Informatics

Background:

  • Cardiovascular drug development relies on comprehensive literature synthesis.
  • Efficiently screening scientific literature is crucial for identifying drug indications, mechanisms, biomarkers, and outcomes.
  • Current literature screening methods can be time-consuming and resource-intensive.

Purpose of the Study:

  • To investigate the performance, cost, and prompt engineering trade-offs of three large language models (LLMs).
  • To assess the potential of LLMs in accelerating the literature screening process for cardiovascular drug development.
  • To provide insights into optimizing LLM application for biomedical research.

Main Methods:

  • Evaluation of three distinct large language models.
  • Analysis of model performance metrics relevant to literature screening.
  • Assessment of associated costs and prompt engineering strategies.
  • Comparative analysis of LLM capabilities in synthesizing cardiovascular drug development literature.

Main Results:

  • Demonstrated significant acceleration in literature screening compared to traditional methods.
  • Identified varying performance and cost efficiencies across the evaluated LLMs.
  • Highlighted the impact of prompt engineering on the accuracy and relevance of LLM outputs.
  • Provided a framework for selecting appropriate LLMs based on specific research needs.

Conclusions:

  • Large language models show promise in expediting cardiovascular drug development literature synthesis.
  • Careful consideration of model choice, cost, and prompt design is essential for effective implementation.
  • LLMs can enhance the efficiency of identifying key information for drug discovery and development.